Man­u­fac­tur­ing roundup: Gen­Bio­Pro looks to counter Mis­sis­sip­pi trig­ger law; Pis­gah Labs to in­vest $55M in NC ex­pan­sion  

As the is­sues from the Roe V. Wade de­ci­sion con­tin­ue to cas­cade in var­i­ous cir­cles, in­clud­ing the biotech world, one man­u­fac­tur­er is look­ing to push back against state law.

Ac­cord­ing to a re­port from Bloomberg BNN, mifepri­s­tone man­u­fac­tur­er Gen­Bio­Pro is look­ing to chal­lenge a Mis­sis­sip­pi an­ti-abor­tion law set in­to mo­tion by the US Supreme Court’s re­ver­sal of Roe v. Wade, stat­ing that the move is keep­ing its prod­uct off the shelves.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters